Purchase Order 75N95023P00740

Award Date 9/11/23
Potential Completion Date 9/10/24
Potential Value $14K
Contracting Federal Agency
National Institute on Drug Abuse
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Branford, CT 06405, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Institute on Aging awarded a $176,609.00 firm fixed price purchase order to Isoplexis Corporation for an ISOPLEXIS ISOSPARK DUO single cell proteomics platform. The contract was awarded on September 13, 2022 with a completion date of October 13, 2022. The original pre-solicitation notice sought information from qualified small businesses capable of providing the IsoSpark Duo instrument, laptop computer, and...
This is a $34,400.00 firm fixed-price purchase order contract awarded by the National Institute on Aging (NIA), a civilian federal agency, to Bruker Cellular Analysis, Inc., a self-certified small disadvantaged business manufacturer of goods. The contract is for an ISOSPARK DUO SERVICE AGREEMENT and does not have a set-aside designation. The contract supports Bruker's provision of advanced laboratory equipment, consumables, and services, with a focus on supporting COVID-19 related research and...
This is a $99,997.63 firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Isoplexis Corporation for the delivery of ISO LIGHT SYSTEM. The award was not set aside and has a performance period ending on May 14, 2021. Isoplexis Corporation is a biotechnology company that specializes in single cell proteomics and has previously received federal contract awards and grants from agencies such as the National...
This federal contract award, valued at $126,420.00, was made by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), to IsoPlexis Corporation. The award is for the procurement of an IsoPlexis IsoSpark single cell proteomics platform, which includes the IsoSpark system, IsoSpeak informatics software, accessory kit, installation and training services. The platform provides automated, highly multiplexed live single cell...
This is a firm fixed price purchase order contract awarded by the Department of Veterans Affairs (VA) to Isoplexis Corporation, a biotechnology company that specializes in single cell proteomics. The contract, valued at $99,350.00, is for the provision of Isoplexis' ISOSPARK services, systems, and accessories. The contract does not have a set-aside designation. Based on the provided information, Isoplexis has received prior federal contract awards and grants from agencies such as the National...
The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $32,986.00 firm fixed price purchase order to Life Technologies Corporation, a for-profit manufacturer, for an iBright FL 1500 Imaging System. This non-competitive award was issued under simplified acquisition procedures without a set-aside designation. The solicitation was posted on March 30, 2020 and the award was made on April 8, 2020 for delivery within 6...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to I.S.S. (USA) Inc., doing business as ISS. The contract, valued at $25,000.00, is for the delivery of scientific instruments and equipment. ISS, a manufacturer of fluorescence instrumentation, has over 30 years of experience providing products to various federal agencies, including the National Institutes of Health, National Institute of Child Health and Human Development, and...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, awarded a $109,725.00 firm fixed price purchase order contract to Bruker Cellular Analysis, Inc. for the BEACON ESSENTIAL SERVICE PLAN. Bruker Cellular Analysis, Inc. is a small disadvantaged business that manufactures optofluidic platforms and consumables for single cell analysis. This award, which has a completion date of June 29, 2025, is likely part of...
This firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Bruker Cellular Analysis, Inc. for the provision of consumable lab supplies, specifically Optoselect 11k and 20k chips. The contract, valued at $14,654.00, will run through October 31, 2024. Bruker Cellular Analysis, Inc. is a small disadvantaged business that manufactures the optofluidic platforms and related...
The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $20,148 firm fixed price delivery order to Beckman Coulter Inc. US Customer Operations Division. This order is for a BIOMEK I7 HYBRID SERVICE AGREEMENT RENEWAL to be performed in Potomac, Maryland from November 2023 through November 2024. The National Center for Advancing Translational Sciences supports clinical and translational science awards and grants to...

Isoplexis Corporation, a division of Bruker Cellular Analysis, Inc., was awarded a $14,080.50 firm fixed price purchase order by the National Institutes of Health's National Center for Advancing Translational Sciences to provide ISOSPARK service agreement. The services will be performed in Branford, Connecticut over a one year period ending September 2024. No subcontractors or set aside designations were identified. The purchase order is likely in support of the National Institutes of Health's efforts to advance translational sciences and move research discoveries into clinical applications and improved patient outcomes.

Generated 12/19/23, 6:26 PM